Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.

NCT00356148 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT00356148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00356148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.
Lead sponsor
Marmara University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
May 31, 2010
Enrollment
372 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer